4//SEC Filing
Coste Catherine 4
Accession 0001209191-23-041800
CIK 0001811115other
Filed
Jul 6, 8:00 PM ET
Accepted
Jul 7, 4:28 PM ET
Size
5.8 KB
Accession
0001209191-23-041800
Insider Transaction Report
Form 4
Renalytix plcRNLX
Coste Catherine
Director
Transactions
- Award
Employee Stock Option (right to buy)
2023-07-06+190,000→ 190,000 totalExp: 2033-07-05→ Ordinary Shares (190,000 underlying)
Footnotes (2)
- [F1]The exercise price is 1.025 pounds sterling. The U.S. dollar equivalent of the exercise price is $1.301 using the Bank of England rate as of July 6, 2023 (1.00 pound sterling = $1.269).
- [F2]One third (1/3rd) of the shares subject to the option award shall vest on July 6, 2024, and one eighth (1/8th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service.
Documents
Issuer
Renalytix plc
CIK 0001811115
Entity typeother
Related Parties
1- filerCIK 0001821432
Filing Metadata
- Form type
- 4
- Filed
- Jul 6, 8:00 PM ET
- Accepted
- Jul 7, 4:28 PM ET
- Size
- 5.8 KB